The benefit of preoperative cardiac evaluation in the diabetic patient
undergoing peripheral vascular surgery is uncertain. To investigate t
his issue we performed a retrospective review of 192 procedures perfor
med in diabetic patients for chronic lower extremity arterial occlusiv
e disease. The incidence of adverse postoperative cardiac events was d
etermined, as well as its association with several preoperative factor
s including symptoms of coronary artery disease (CAD), extent and resu
lts of preoperative noninvasive cardiac evaluation, and operative site
(aorta vs. lower extremity). The overall death and cardiac complicati
on rates were 10.2% for lower extremity and 25.7% for aortic procedure
s (p = 0.02). For myocardial infarction and cardiac death alone, the r
ates were 5.1% and 5.7%, respectively (p > 0.10). Although a history o
f symptomatic CAD predicted the occurrence of any cardiac complication
(28.3% vs. 8.2% [p < 0.01] for the aortic and lower extremity revascu
larization groups combined), no factor was found to be associated with
the occurrence of myocardial infarction and cardiac death alone. In p
atients with a history of symptomatic CAD, there was no significant di
fference in the incidence of complications whether or not preoperative
noninvasive cardiac testing was performed (28.1% vs. 28.6%, p > 0.10)
or, if testing was performed, if the results were abnormal or normal
(35.3% vs. 20.0%, p > 0.10). Similar results were obtained in patients
with no history of symptomatic CAD. In summary, this retrospective re
view of our experience with noninvasive evaluation to detect CAD in di
abetic patients undergoing peripheral vascular surgery failed to show
any benefit in terms of reducing the incidence of postoperative cardia
c events.